Search Results - "Bergsbaken, Jason"

Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities? by Przybylski, Daniel J, Bergsbaken, Jason J, Piccolo, Jennifer K

“…Objective The purpose of this review was to summarize the triumphs and pitfalls of tyrosine kinase inhibitor (TKI) and immune checkpoint inhibitor (ICI)…”
Get full text

Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic by Quinn, Caroline S, Bergsbaken, Jason J, Blessinger, Emily J, Piccolo, Jennifer K

“…Objective Chemotherapy-induced nausea and vomiting (CINV) is a common and potentially debilitating adverse effect of chemotherapy. Refractory CINV can be…”
Get full text

Implementation of a chemotherapy stewardship process by Hennes, Emily R, Reed, Michael, Mably, Mary, Jared, Jason, Bergsbaken, Jason J, Deming, Dustin, Callander, Natalie, O’Regan, Ruth

“…To design and implement a chemotherapy stewardship process to optimize the location of chemotherapy administration in an effort to decrease the number of…”
Get full text

PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and cost by Hennes, Emily R, Dow-Hillgartner, Elizabeth N, Bergsbaken, Jason J, Piccolo, Jennifer K

“…Purpose To summarize similarities and differences in efficacy, safety, and cost of available PARP-inhibitors and offers pearls to distinguish subtle nuances…”
Get full text

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation by Peh, Keng Hee, Przybylski, Daniel J, Fallon, Michael J, Bergsbaken, Jason J, Hutson, Paul R, Yu, Menggang, Deming, Dustin A, Burkard, Mark E

“…Purpose Molecular tumor boards provide precision treatment recommendations based on cancer genomic profile. However, practical barriers limit their benefits…”
Get full text

Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicities by Renna, Catherine E, Dow, Elizabeth N, Bergsbaken, Jason J, Leal, Ticiana A

“…Introduction The development of immune checkpoint inhibitors has revolutionized cancer treatment and is now a part of the treatment paradigm for several…”
Get full text

Automated parenteral chemotherapy dose-banding to improve patient safety and decrease drug costs by Fahey, Olivia G, Koth, Sara M, Bergsbaken, Jason J, Jones, Heather A, Trapskin, Philip J

“…Purpose To improve patient safety and reduce drug waste through implementation of automated parenteral chemotherapy dose-banding within an electronic health…”
Get full text

Implementing value assessment in oncology practice: A single-center experience by Saunders, Katherine, Mably, Mary S, Shull, Sara S, Jones, Heather, Leal, Ticiana A, Bergsbaken, Jason J

“…Cancer treatment costs in the United States are rising. Evidence suggests that increased costs do not always correlate with improved outcomes. Several…”
Get full text

Hypertension and QT interval prolongation associated with targeted systemic cancer therapies by Fahey, Olivia G, Piccolo, Jennifer K, Bergsbaken, Jason J, N Dow-Hillgartner, Elizabeth

“…Objective To summarize the proposed mechanisms behind hypertension and QT interval prolongation associated with use of targeted systemic cancer therapies and…”
Get full text

Pharmacist participation in infection prevention: An innovative approach to monitoring compliance with the Five Moments for Hand Hygiene in a large academic medical center by Bergsbaken, Jason, PharmD, Schulz, Lucas T., PharmD, BCPS, Trapskin, Philip J., PharmD, BCPS, Marx, John, MPH, Safdar, Nasia, MD, PhD

“…Using pharmacy residents as covert observers, we evaluated compliance with hand hygiene and contact precautions among 101 unique health care workers on…”
Get full text

A quality improvement project to implement oral anticoagulant thromboprophylaxis in ambulatory gynecologic cancer patients undergoing chemotherapy (162) by Zhang, Ran, Bergsbaken, Jason, Tierney, Susan, Wallace, Sumer, Kushner, David, Hartenbach, Ellen

Get full text

P-237 Bendamustine (B) is associated with low response rates in heavily pretreated relapsed refractory multiple myeloma (RRMM) by Gahvari, Zhubin, Schmidt, Timothy, Brunner, Matthew, Bergsbaken, Jason, Callander, Natalie

Get full text

Thromboembolic events in gynecologic cancer patients treated with chemotherapy (380) by Zhang, Ran, Stewart, Taylor, Tetreault, Kaitlin, Alexandridis, Roxana, Bergsbaken, Jason, Wallace, Sumer, Kushner, David, Hartenbach, Ellen

Get full text

Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center by Mulkerin, Daniel L, Bergsbaken, Jason J, Fischer, Jessica A, Mulkerin, Mary J, Bohler, Aaron M, Mably, Mary S

“…Use of oral chemotherapy is expanding and offers advantages while posing unique safety challenges. ASCO and the Oncology Nursing Society jointly published…”
Get full text

nitiatives to Improve Safety of Oral Anticancer Agents Delivered by Community Pharmacists by Klaus Meier, Jason Bergsbaken, Shinya Suzuki

“…With the recent growth in oral anticancer agents (OAA), pharmacists working in the community have recognised the urgent need to develop safe and effective…”
Get full text

Multidisciplinary optimization of oral chemotherapy delivery at the UW Carbone Cancer Center by Mulkerin, Daniel, Mably, Mary, Bergsbaken, Jason, Schuhmacher, Kari, Nemergut, Chris, Bohler, Aaron, Fischer, Jessica

“…Abstract only 58 Background: Use of oral chemotherapy is expanding and offers advantages but introduces unique safety challenges. ASCO and ONS addressed these…”
Get full text

Medication safety pharmacy technician in a large, tertiary care, community hospital by Brown, Kathryn N, Bergsbaken, Jason, Reichard, Jeffrey S

Get full text

Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function by FERMIANO, MARIANA, BERGSBAKEN, JASON, KOLESAR, JILL M

“…PURPOSEThe pharmacology, pharmacokinetics, clinical efficacy, safety, dosage, administration, and current role in therapy of a recently approved agent for…”
Get full text

Vaccination Adherence Post-Transplant by Ninos, Cameron, Swiecichowski, Mandy, Miller, Eric, Bergsbaken, Jason, Fierek, Sarah, Swing, Shane, Cancelliere, Victoria, Hall, Aric C.

Get full text

597 - Vaccination Adherence Post-Transplant by Ninos, Cameron, Swiecichowski, Mandy, Miller, Eric, Bergsbaken, Jason, Fierek, Sarah, Swing, Shane, Cancelliere, Victoria, Hall, Aric C.

Get full text